Modular fluidic systems to analyze tiny patient samples
Official title: Manufacture and Assembly of Thermoplastic, Modular, Integrated Fluidic Systems
Funded at University of Kansas Lawrence · NIH-11336092 · Data updated 2026-11-12
A research project aims to build compact, easy-to-use fluidic devices to run complex liquid biopsy tests on very small patient samples, with a focus on cancer, stroke, and bacterial infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project start | September 16, 2015 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $263,463 |
| NIH project number | 2P41EB020594-12 |
| Project ID | NIH-11336092 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer, stroke, or drug-resistant bacterial infections who may benefit from liquid biopsy testing.
✕Less likely to help
Patients not undergoing liquid biopsy testing or whose samples are not mass-limited may see no direct benefit.
What this research studies
This project develops thermoplastic, modular fluidic systems that combine multiple assay steps into one platform. It targets mass-limited samples so clinicians can run precise liquid biopsy tests without transferring small target amounts between instruments. The work focuses on manufacturing standards and integration to simplify workflows and reduce reagent use. It’s designed so hospital labs can adopt the technology for routine clinical use.
Why it matters
Potential benefit: If successful, patients could benefit from faster, simpler, and more accurate liquid biopsy testing using smaller blood or other sample volumes.
How similar studies have gone: Previous work shows that integrated fluidic systems can streamline complex assays, though this project aims to advance manufacturing and standardization.
Where this research is happening
-
University of Kansas Lawrence
Lawrence, United States Active
Researchers
- Principal investigator: Park, Sunggook — University of Kansas Lawrence
- Study coordinator: Park, Sunggook
Related research
Other NIH-funded projects on the same topics.
-
KC Youth Violence Prevention Center: A comprehensive plan to reduce youth violence
A program in Kansas City aims to reduce youth violence and deaths by applying a coordinated, community-focused approach.
-
Gene regulation and the genetic basis of complex traits (how our genes influence survival and trait differences)
Researchers are studying how genetic differences that affect gene regulation contribute to when and how people survive and reproduce, especially in natural populations.
-
Finding new treatments and understanding how congenital glycosylation disorders work
A research project aims to uncover how certain congenital glycosylation disorders develop and identify existing drugs that could help treat DPAGT1-CDG.
-
How ADP-ribosylation controls our antiviral defenses
Researchers are studying a cellular modification called ADP-ribosylation and how it helps the body fight viruses, with a focus on how coronaviruses interact with this process.
-
Chemoenzymatic synthesis to make biologically active molecules using enzyme libraries
A scientist team will develop enzyme-based methods to make complex drug-like molecules that could help fight cancer and other diseases.
-
DNA breaks and repair in opioid addiction
This project looks at how DNA damage and repair in brain cells may influence opioid addiction and relapse in people and animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.